Gemcitabine is part of the family of nucleosides which are compounds constituted of two chemical parts: a sugar bound to a nucleobase through a glycosidic bond. As any nucleoside can have two…
This is to report on a new tendency in the jurisdiction of the Federal Patent Court to use the prerequisite of enabling disclosure (Art. 83 EPC) as an unpredictable rule of reason for patentability…
The Borgarting Court of Appeal overturned the district court decision which revoked the patents in suit for lack of inventive step. The Court held that even if oxycodone had been known and used to…
The patent concerned claims a method of cooling animals characterized in that the animals are cooled in a milking stall so that the animals go to the milking stall spontaneously. The patentee added a…
In this case the Court held that a previous patent application and other scientific publications which did not disclose the invention in a manner sufficiently complete for it to be carried out by a…
While the European Commission is still struggling to implement a Community Patent and a European Patent litigation system, it is worthwhile to have a look to the results the existing system is…
This judgement is one of many issued in the worldwide litigation pending between Novartis and Johnson & Johnson concerning Novartis' patent for ophthalmically compatible extended wear contact lenses…
The Court of Appeal upheld the High Court's finding that Novartis' patent for ophthalmically compatible extended wear contact lenses was invalid for insufficiency. The Court of Appeal held that the…
Otis Elevator Company (hereinafter referred to as “Otis”) is the owner of different European patents covering elevators systems.
Considering that some Schindler elevator models reproduced certain…
